Cargando…
Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
Background: CD38 is involved in the adenosine pathway, which represents one of the immunosuppressive mechanisms in cancer. CD38 is broadly expressed across immune cell subsets, including human macrophages differentiated in vitro from monocytes, but expression by tissue-resident macrophages remains t...
Autores principales: | Lam, Jian Hang, Ng, Harry Ho Man, Lim, Chun Jye, Sim, Xin Ni, Malavasi, Fabio, Li, Huihua, Loh, Josh Jie Hua, Sabai, Khin, Kim, Joo-Kyung, Ong, Clara Chong Hui, Loh, Tracy, Leow, Wei Qiang, Choo, Su Pin, Toh, Han Chong, Lee, Ser Yee, Chan, Chung Yip, Chew, Valerie, Lim, Tong Seng, Yeong, Joe, Lim, Tony Kiat Hon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738266/ https://www.ncbi.nlm.nih.gov/pubmed/31552039 http://dx.doi.org/10.3389/fimmu.2019.02093 |
Ejemplares similares
-
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
por: Ng, Harry Ho Man, et al.
Publicado: (2020) -
Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up
por: Lim, Chong Teik, et al.
Publicado: (2020) -
Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
por: Lim, Chun Jye, et al.
Publicado: (2021) -
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
por: Cheung, Chun Chau Lawrence, et al.
Publicado: (2023) -
Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib
por: Tan, Aaron C, et al.
Publicado: (2021)